Neurological conditions that mimic Guillain-Barré Syndrome and how to differentiate them
GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been detected in Pune. Early sym ...
Research Reveals TMJ As Neurogenic, Links To Joint Pain
Schematic depicting the involvement of regional sympathetic nerves in the mediation of pain in early-stage TMJ-OA. GA, UNITED STATES, Febru ...
Auxilium’s 3D printer builds medical devices on the International Space Station
Via a collaboration with Nasa, Auxilium has installed a 3D printer on the ISS to test the promise of manufacturing in microgravity.
The Scientist2d
“Man on Fire” Syndrome, Ion Channels, and the Quest for Safer Pain Treatments
In 2004, a research group at Peking University First Hospital discovered a mutation in the gene coding for a sodium-channel ...
Guillain-Barre syndrome: Case of mistaken identity; when immune system attacks nerves
On the cold morning of January 31, 2006, Nitin Narain, a 25-year-old Delhi native, began experiencing unusual fatigue, ...
Hosted on MSN3d
Vitamin B12 deficiency: Signs of nerve damage 'may become permanent' without proper treatment, warns dietitian
Vitamin deficiencies, although seemingly harmless, can cause serious health complications when undetected. Among the more ...
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
“We are pleased to welcome Jesse to the Axogen team," said Michael Dale, Chief Executive Officer, and Director, Axogen. "His extensive experience in regulatory strategy and deep understanding of the ...
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...
Scientific American6d
What Is Journavx, the New Opioid-Free Painkiller from Vertex?
The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...
FDA approves first non-opioid pain medicine in more than 20 years
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
What is Non-Opioid Pain Medication? Journavx Approved by FDA
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.